ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC By Ogkologos - May 21, 2026 74 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TOMBOLA study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR An existing blood test for ovarian cancer has been re-evaluated. The... October 28, 2020 Bride Learns Sign Language, Surprises Groom’s Deaf Parents & Signs Her... January 11, 2022 Vegetarian Recipes September 4, 2020 EMA Recommends Extension of Indications for Atezolizumab September 28, 2020 Load more HOT NEWS Safety and Preliminary Signs of Activity of OMO-103, a MYC Inhibitor,... Clinical Trials in Genitourinary Cancers: TALAPRO-2, KEYNOTE-905, and COSMIC-313 Embracing Lung Cancer Survivorship FDA Approves Olaparib with Abiraterone and Prednisone (or Prednisolone) for BRCA-mutated...
